Characterization of dopamine-dependent rewarding and locomotor stimulant effects of intravenously-administered methylphenidate in rats

Neuroscience

Volumn 141, Issue 3, 2006, Pages 1457-1468

  Sellings, L H L ^a   McQuade, L E ^a   Clarke, P B S ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

cis flupenthixol; conditioned place preference; dopamine; nucleus accumbens core; nucleus accumbens medial shell; olfactory tubercle

Indexed keywords

DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE TRANSPORTER; FLUPENTIXOL; METHYLPHENIDATE; OXIDOPAMINE; RADIOLIGAND;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC TRANSMISSION; LIGAND BINDING; LOCOMOTION; MALE; NONHUMAN; NUCLEUS ACCUMBENS; OLFACTORY BULB; PLACE PREFERENCE; PRIORITY JOURNAL; RAT; REWARD; STATISTICAL SIGNIFICANCE;

ADRENERGIC AGENTS; ANALYSIS OF VARIANCE; ANIMALS; AUTORADIOGRAPHY; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; CONDITIONING (PSYCHOLOGY); CORPUS STRIATUM; DOPAMINE; DOPAMINE ANTAGONISTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FLUPENTHIXOL; INJECTIONS, INTRAVENOUS; MALE; METHYLPHENIDATE; MOTOR ACTIVITY; OXIDOPAMINE; PROTEIN BINDING; RATS; RATS, LONG-EVANS; REWARD; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 33746632143     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.04.040     Document Type: Article

References (44)

1. Barrett S.P., Darredeau C., Bordy L.E., and Pihl R.O. Characteristics of methylphenidate misuse in a university student sample. Can J Psychiatry 50 (2005) 457-461
2. Bergman J., Madras B.K., Johnson S.E., and Spealman R.D. Effects of cocaine and related drugs in nonhuman primates. III. Self-administration by squirrel monkeys. J Pharmacol Exp Ther 251 (1989) 150-155
3. Berridge C.W., Stratford T.L., Foote S.L., and Kelley A.E. Distribution of dopamine β-hydroxylase-like immunoreactive fibers within the shell subregion of the nucleus accumbens. Synapse 27 (1997) 230-241
4. Boye S.M., Grant R.J., and Clarke P.B.S. Disruption of dopaminergic neurotransmission in nucleus accumbens core inhibits the locomotor stimulant effects of nicotine and D-amphetamine in rats. Neuropharmacology 40 (2001) 792-805
5. Campbell A., Villavicencio A.T., Yeghiayen S.K., Balikian R., and Baldessarini R.J. Mapping of locomotor behavioral arousal induced by microinjections of dopamine within nucleus accumbens septi of rat forebrain. Brain Res 771 (1997) 55-62
6. Cervo L., and Samanin R. Effects of dopaminergic and glutamatergic receptor antagonists on the acquisition and expression of cocaine conditioning place preference. Brain Res 673 (1995) 242-250
7. Clarke P.B.S., White N.M., and Franklin K.B. 6-Hydroxydopamine lesions of the olfactory tubercle do not alter (+)-amphetamine-conditioned place preference. Behav Brain Res 36 (1990) 185-188
8. Delfs J.M., Zhu Y., Druhan J.P., and Aston-Jones G.S. Origin of noradrenergic afferents to the shell subregion of the nucleus accumbens. Anterograde and retrograde tract- tracing studies in the rat. Brain Res 806 (1998) 127-140
9. Di Chiara G., Bassareo V., Fenu S., De Luca M.A., Spina L., Cadoni C., Acquas E., Carboni E., Valentini V., and Lecca D. Dopamine and drug addiction. the nucleus accumbens shell connection. Neuropharmacology 47 Suppl 1 (2004) 227-241
10. Everitt B.J., and Wolf M.E. Psychomotor stimulant addiction. a neural systems perspective. J Neurosci 22 (2002) 3312-3320
11. Gerasimov M.R., Franceschi M., Volkow N.D., Gifford A., Gatley S.J., Marsteller D., Molina P.E., and Dewey S.L. Comparison between intraperitoneal and oral methylphenidate administration. A microdialysis and locomotor activity study. J Pharmacol Exp Ther 295 (2000) 51-57
12. Ikemoto S. Ventral striatal anatomy of locomotor activity induced by cocaine, D-amphetamine, dopamine and D1/D2 agonists. Neuroscience 113 (2002) 939-955
13. Ikemoto S. Involvement of the olfactory tubercle in cocaine reward. intracranial self-administration studies. J Neurosci 23 (2003) 9305-9311
14. Ikemoto S., and Wise R.A. Mapping of chemical trigger zones for reward. Neuropharmacology 47 Suppl 1 (2004) 190-201
15. Ikemoto S., Qin M., and Liu Z.H. The functional divide for primary reinforcement of D-amphetamine lies between the medial and lateral ventral striatum. is the division of the accumbens core, shell and olfactory tubercle valid?. J Neurosci 25 (2005) 5061-5065
16. Johanson C.E., and Fischman M.W. The pharmacology of cocaine related to its abuse. Pharmacol Rev 41 (1989) 3-52
17. Jonsson G. Chemical lesioning techniques. monoamines. In: Björklund A.H.T. (Ed). Handbook of chemical neuroanatomy Vol. 1 (1983), Elsevier, Amsterdam 463-507
18. Kelly P.H., and Iversen S.D. Selective 6-OHDA-induced destruction of mesolimbic dopamine neurons. abolition of psychostimulant-induced locomotor activity in rats. Eur J Pharmacol 40 (1976) 45-56
19. Kollins S.H., MacDonald E.K., and Rush C.R. Assessing the abuse potential of methylphenidate in nonhuman and human subjects. a review. Pharmacol Biochem Behav 68 (2001) 611-627
20. Koob G.F., Sanna P.P., and Bloom F.E. Neuroscience of addiction. Neuron 21 (1998) 467-476
21. Kuczenski R., and Segal D.S. Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine. comparison with amphetamine. J Neurochem 68 (1997) 2032-2037
22. Martin-Iverson M.T., Ortmann R., and Fibiger H.C. Place preference conditioning with methylphenidate and nomifensine. Brain Res 332 (1985) 59-67
23. Matsubara S., Matsubara R., Kusumi I., Koyama T., and Yamashita I. Dopamine D1, D2 and serotonin2 receptor occupation by typical and atypical antipsychotic drugs in vivo. J Pharmacol Exp Ther 265 (1993) 498-508
24. Meririnne E., Kankaanpaa A., and Seppala T. Rewarding properties of methylphenidate. sensitization by prior exposure to the drug and effects of dopamine D1- and D2-receptor antagonists. J Pharmacol Exp Ther 298 (2001) 539-550
25. Mithani S., Martin-Iverson M.T., Phillips A.G., and Fibiger H.C. The effects of haloperidol on amphetamine- and methylphenidate-induced conditioned place preferences and locomotor activity. Psychopharmacology (Berl) 90 (1986) 247-252
26. Nomikos G.G., and Spyraki C. Cocaine-induced place conditioning. importance of route of administration and other procedural variables. Psychopharmacology (Berl) 94 (1988) 119-125
27. Parran Jr. T.V., and Jasinski D.R. Intravenous methylphenidate abuse. Prototype for prescription drug abuse. Arch Intern Med 151 (1991) 781-783
28. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates (1997), Academic Press, San Diego, CA
29. Pijnenburg A.J., Honig W.M., and van Rossum J.M. Effects of antagonists upon locomotor stimulation induced by injection of dopamine and noradrenaline into the nucleus accumbens of nialamide-pretreated rats. Psychopharmacologia 41 (1975) 175-180
30. Roberts D.C., Corcoran M.E., and Fibiger H.C. On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine. Pharmacol Biochem Behav 6 (1977) 615-620
31. Roberts D.C., Koob G.F., Klonoff P., and Fibiger H.C. Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens. Pharmacol Biochem Behav 12 (1980) 781-787
32. Roberts D.C., Zis A.P., and Fibiger H.C. Ascending catecholamine pathways and amphetamine-induced locomotor activity. importance of dopamine and apparent non-involvement of norepinephrine. Brain Res 93 (1975) 441-454
33. Sellings L.H.L., and Clarke P.B.S. Segregation of amphetamine reward and locomotor stimulation between nucleus accumbens medial shell and core. J Neurosci 23 (2003) 6295-6303
34. Sellings L.H.L., McQuade L.E., and Clarke P.B.S. Evidence for multiple sites within rat ventral striatum mediating cocaine conditioned place preference and locomotor activation. J Pharmacol Exp Ther 317 (2006) 1178-1187
35. Sora I., Wichems C., Takahasi N., Li X.F., Zeng Z., Revay R., Lesch K.P., Murphy D.L., and Uhl G.R. Cocaine reward models. conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice. Proc Natl Acad Sci U S A 95 (1998) 7699-7704
36. Spyraki C., Fibiger H.C., and Phillips A.G. Cocaine-induced place preference conditioning. lack of effects of neuroleptics and 6-hydroxydopamine lesions. Brain Res 253 (1982) 195-203
37. Spyraki C., Nomikos G.G., and Varonos D.D. Intravenous cocaine-induced place preference. attenuation by haloperidol. Behav Brain Res 26 (1987) 57-62
38. Subhan F., Deslandes P.N., Pache D.M., and Sewell R.D. Do antidepressants affect motivation in conditioned place preference?. Eur J Pharmacol 408 (2000) 257-263
39. Swanson J.M., and Volkow N.D. Serum and brain concentrations of methylphenidate. implications for use and abuse. Neurosci Biobehav Rev 27 (2003) 615-621
40. Versteeg D.H., Van Der Gugten J., De Jong W., and Palkovits M. Regional concentrations of noradrenaline and dopamine in rat brain. Brain Res 113 (1976) 563-574
41. Volkow N.D., Fowler J.S., Wang G.J., and Swanson J.M. Dopamine in drug abuse and addiction. results from imaging studies and treatment implications. Mol Psychiatry 9 (2004) 557-569
42. Volkow N.D., and Swanson J.M. Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. Am J Psychiatry 160 (2003) 1909-1918
43. Weiner I., Gal G., Rawlins J.N.P., and Feldon J. Differential involvement of the shell and core subterritories of the nucleus accumbens in latent inhibition and amphetamine-induced activity. Behav Brain Res 81 (1996) 123-133
44. Wise R.A. Dopamine, learning and motivation. Nat Rev Neurosci 5 (2004) 483-494